Source link : https://www.newshealth.biz/health-news/nipocalimab-shows-sustained-efficacy-in-myasthenia-gravis/
SAVANNAH, Ga. — Investigational nipocalimab lessened disease severity in generalized myasthenia gravis (gMG), the phase III Vivacity-MG3 trial showed. The primary endpoint was the change in Myasthenia Gravis Activities of Daily Living (MG-ADL) scores from baseline to the average over weeks 22, 23, and 24 in seropositive patients with gMG. The MG-ADL scale ranges from […]
Author : News Health
Publish date : 2024-10-16 21:47:09
Copyright for syndicated content belongs to the linked Source.
